Responding to Covid-19 in pharmaceutical supply chains

Assessing the impact of the Covid-19 pandemic on supply chain and logistical operations through the analysis of short-term and long-term responses to disruption

Add bookmark


We respect your privacy, by clicking "Download Your Copy" you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts, online learning opportunities and agree to our User Agreement. You have the right to object . In addition, you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. For further information on how we process and monitor your personal data click here. You can unsubscribe at any time.

The social and economic implications of the Covid-19 pandemic have been felt on a global scale, as millions of people were forced into lockdown, hundreds of thousands of businesses stalled their operations as healthcare systems were pushed to breaking point.

While the pharmaceutical industry has experienced increased bursts of innovation in digital solutions vaccine development and data sharing, pharma companies have also been burdened with the obligation to maintain supply chains for existing treatments and services.

In this report, Pharma Logistics IQ assesses the impact of the Covid-19 pandemic on supply chain and logistical operations through the analysis of short-term and long-term responses to disruption. We dive into significant industry trends within pharma and explore the strategic solutions in which pharma leadership can mitigate short and longstanding supply chain disruption.

Download the report to learn:

  • How to manage supply chain risk and disruption when the long-term effects on operations are unknown.
  • The trends affecting supply shortages on manufacturing and supply chains.
  • Ways to strengthen production cycles, diversify manufacturing sites and enhance quality control measures.
  • How to leverage real-world data to overcome disruptions to clinical trials during Covid-19.
  • How to prepare for a digital future in supply chain management.

Download the report to also receive exclusive access to an interview with Jay Galeota, President and Chief Executive Officer for Inheris BioPharma Inc., who discusses his thoughts on how to facilitate innovation within pharma supply chains and gain a competitive advantage in an ever-changing market.

We respect your privacy, by clicking "Download Your Copy" you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts, online learning opportunities and agree to our User Agreement. You have the right to object . In addition, you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. For further information on how we process and monitor your personal data click here. You can unsubscribe at any time.

RECOMMENDED